[larrled]

The administration tears down another Chesterton fence. Herein lies the rub: nobody thinks they are rubber stamping. Finding people who are less likely to approve vaccines because they lack experience in pharma is just another way to be what his critics accuse him of, an antivax simpleton. It’s not necessarily neutral or pro-science to approve less. You might approve bad ones, and not approve good ones. You need people who are experts. You know who are probably the experts in pharmaceutical risk management? Pharma companies.